about
Overutilization of proton-pump inhibitors: what the clinician needs to knowThe Evolution of Stomach Acidity and Its Relevance to the Human MicrobiomeCoping with low pH: molecular strategies in neutralophilic bacteriaConfounding in the association of proton pump inhibitor use with risk of community-acquired pneumoniaEffects of long-term PPI treatment on producing bowel symptoms and SIBO.Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.Adverse effects of long-term proton pump inhibitor therapy.Role of Helicobacter pylori infection on nutrition and metabolism.Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infectionNew non-invasive test of gastric acid secretion for use in children.Duodenal bacterial overgrowth during treatment in outpatients with omeprazoleBacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota.Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection.A low gastric pH mouse model to evaluate live attenuated bacterial vaccines.The role of gastric acid in preventing foodborne disease and how bacteria overcome acid conditions.The Effect of Helicobacter pylori Infection, Aging, and Consumption of Proton Pump Inhibitor on Fungal Colonization in the Stomach of Dyspeptic Patients.Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious GastroenteritisNon-immunological defence mechanisms of the gutInfluence of gastric acid on susceptibility to infection with ingested bacterial pathogensGastrointestinal tuberculosis is not associated with proton pump inhibitors: a retrospective cohort study.Omission of breakfast and risk of gastric cancer in MexicoAchlorhydria is associated with gastric microbial overgrowth and development of cancer: lessons learned from the gastrin knockout mouse.Comparison of Gastric Microbiota Between Gastric Juice and Mucosa by Next Generation Sequencing MethodExtensive atrophic gastritis increases intraduodenal hydrogen gas.Vibrio cholerae bacteremia associated with gastrectomyGastroenterology in developing countries: issues and advances.Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms.Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea, and growth retardation.Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia.Stress prophylaxis in intensive care unit patients and the role of enteral nutrition.Indications and safety of proton pump inhibitor drug use in patients with cancer.Safety of medication options for treating pediatric esophagitis.Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.The impact of proton pump inhibitor therapy on patients with liver disease.Association Between Use of Proton Pump Inhibitors and a Clostridium difficile-Associated Disease Outbreak: Case-Control Study.Life-threatening manifestation of diarrhea.Gastric acid secretion and enteric infection in BangladeshPharmacogenomic testing: the case for CYP2C19 proton pump inhibitor gene-drug pairs.
P2860
Q24634086-0B451903-410B-4BA7-BFF4-969DF0D663E6Q26801813-6BF1E051-A98C-4F47-9110-09E9AD723018Q26853737-0F7E98AA-DE18-486B-818C-D61BB481BBB6Q28396345-CE74D466-4F81-43BF-96D2-CCEC6222647BQ33448825-60778407-2750-4E40-BDFA-E39206785B5FQ33940198-CBE8FFB4-F09A-41B2-8B5C-CA52C120705FQ34167899-AD041656-26C6-4E37-90E4-0D2821BAF872Q34255432-294803B0-6AC1-448E-AE66-1DA91AD3B2BDQ34321989-71033D33-E07E-41F6-87BA-6BA66E90BA58Q34376925-0B96A50D-D134-47B9-B0AF-5CDBE2CD7FCCQ34378388-21B27607-BD1D-407C-85A3-DEE0334EA9E4Q34409933-FCF30C03-1EAF-4F58-87F7-7901BDBC3F7AQ34610525-15D79DB5-8220-4B83-9619-6843ECB3E4B9Q34695018-8885BBFB-754B-4D0C-8B02-73B37BF46EB9Q35086704-7714D9EC-00ED-430A-86A3-2F9923E24382Q35180934-0C1301F8-DC52-4508-BED9-035063998C15Q36037614-B1C51EDB-8E29-4CCD-AE24-D1AC756A50BDQ36229626-031A788B-A3A1-4E0C-84EF-D129BA794D3BQ36380450-990203E8-1A16-4D10-B2F0-17787CB6BD42Q36421507-C708E1BA-3379-4890-9FD6-651DF9218D3BQ36541209-40B3B278-DD04-41EB-9C88-D75AB5189775Q36637075-B46F2A48-BFEB-427A-9977-234BA9595D8BQ36652560-FCF8D850-3F27-4FD1-979F-DF30D7D89F54Q36762117-5519ED75-33DF-4BE2-AD9C-8EEB2CBB6674Q36873997-CE93828E-DE50-4D9F-AD3F-6FC28A58D0C8Q37228367-3D96CEBF-F644-473E-B72C-C828C17D7386Q37233997-7DB1BB8D-56E8-44E3-92EB-BA73A64298E2Q37587257-C19F9213-B02F-4292-9BFF-348DB6B60EAFQ37591503-E464EC91-AE65-45C7-B119-6C89D8119205Q37641075-CC91EAF5-71AB-436A-BD50-8C8EC0A881FDQ37993057-F342E55D-D33C-453C-A806-91B093C829E5Q38104388-886F94D1-9994-4AEE-A158-7F30141AB00FQ38442609-4183F264-0C00-441C-BB3E-69582FB257D8Q38645653-9CA1EA1C-BC5A-4E6C-A096-1C521EBEA2A9Q38865456-F73A56AF-1D2F-4E10-8654-E4D66DD5AF45Q39256050-E5FF72B0-703B-4A2F-AD86-E66ED2D3855EQ39417115-1545EA70-79A6-42B3-8D06-8D60E570DEA6Q39768123-89633AE7-85E0-4EA0-8F92-B13C88D61FA5Q40640736-D84A32B4-55C0-4381-925A-D87232BAB16CQ41706384-EC822D93-6BBB-4246-BD3A-BE1B9CE207C3
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Relationship between gastric secretion and infection.
@en
Relationship between gastric secretion and infection.
@nl
type
label
Relationship between gastric secretion and infection.
@en
Relationship between gastric secretion and infection.
@nl
prefLabel
Relationship between gastric secretion and infection.
@en
Relationship between gastric secretion and infection.
@nl
P2860
P356
P1433
P1476
Relationship between gastric secretion and infection.
@en
P2093
P2860
P304
P356
10.1136/GUT.28.1.96
P407
P577
1987-01-01T00:00:00Z